As of December 2024, C-CAT has accumulated genomic and clinical data from >93 000 cancer patients, making it one of the largest cancer genome databases in Japan.19, 20, 21, 22 This comprehensive dataset allowed us to evaluate the association between KRAS variants and OS/treatment efficacy in patients with BTC, providing new insight into BTC biology and future therapeutic strategies. Here, KRAS is linked to cancer.